Expression of melatonin MT1 and MT2 receptors, and RORα1 receptor in transplantable murine Colon 38 cancer

Neuroendocrinology Letters

Volumn 23, Issue SUPPL. 1, 2002, Pages 55-60

  Karasek, Michal ^a   Carrillo Vico, Antonio ^a   Guerrero, Juan M ^a   Winczyk, Katarzyna ^a   Pawlikowski, Marek ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Colon cancer; Melatonin receptors; MT1 receptor; MT2 receptor; RZR ROR receptor

Indexed keywords

6 CHLOROMELATONIN; CELL NUCLEUS RECEPTOR; MELATONIN; MELATONIN RECEPTOR; MEMBRANE RECEPTOR; MESSENGER RNA; RECEPTOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CARCINOGENESIS; COLON CANCER; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; GENETIC CODE; IMMUNODETECTION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 0036257935     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Melatonin in oncology
2. Pineal gland, melatonin and cancer
3. In vitro effects of melatonin on tumor cells
4. Oncostatic action of melatonin: Facts and question marks
5. Antiproliferative effects of melatonin and CGP 52608 on murine Colon 38 adenocarcinoma in vitro and in vivo
6. Somatostatin analogue octreotide and melatonin inhibit bromodeoxyuridine incorporation into cell nuclei and enhance apoptosis the transplantable murine Colon 38 cancer
7. The antiproliferative effects of melatonin on experimental pituitary and colonic tumors
8. Melatonin and RZR/RORα ligand CGP 52608 induce apoptosis in the murine colonic cancer
9. Effect of melatonin and melatonin receptors ligand N-[(4-methoxy-1H-indol-2-yl)methyl]propranamide on murine Colon 38 cancer growth in vitro and in vivo
10. Tumor induction relationship in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure
11. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
12. In vitro and in vivo evidence for orphan nuclear receptor RORα function in bone metabolism
13. Melatonin and the mammalian pineal gland
14. Melatonin receptors step into light: Cloning and classification of subtypes
15. Molecular pharmacology and function of melatonin receptor subtypes
16. Melatonin receptors
17. The orphan receptor family RZR/ROR, melatonin and 5-lipoxygenase: An unexpected relationship
18. Nuclear signalling of melatonin
19. Identification of nuclear receptor mRNAs by RT-PCR amplification of conserved zinc-finger motif sequences
20. Isoform-specific amino-terminal domains dictate DNA-binding properties of RORα, a novel family of orphan hormone nuclear receptors
21. RZRs, a novel class of retionoid related orphan receptors that function as both monomers and homodimers
22. RORγ: The third member of RZR/ROR orphan receptor subfamily that is expressed in skeletal muscle
23. Mechanisms involved in the immunostimulatory effects of melatonin on the human immune system
24. 1a melatonin receptor mRNA in T and B subsets of lymphocytes from rat thymus and spleen
25. Correlation between nuclear melatonin receptor expression and enhanced cytokine production in human lymphocytic and monocytic cell lines
26. Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin-receptor - Mediated signal transduction events
27. Melatonin inhibits growth of cultured human uveal melanoma cells
28. 1B) receptor
29. Inhibition of malignant trophoblastic cell proliferation in vitro and in vivo by melatonin
30. Estorgen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors
31. Melatonin-induced suppression of PC12 cell growth is mediated by its Gi coupled transmembrane receptors
32. Growth-inhibitory activity of melatonin on human androgen-independent DU 145 prostate cancer cells
33. Inhibition of androgen-sensitive LNCaP prostate cancer growth in vitro by melatonin: Association of antiproliferative action of the pineal hormone with mt1 receptor protein expression
34. N1E-115 mouse neuroblastoma cells express MT1 melatonin receptors and produce neurites in response to melatonin
35. The oncostatic action of melatonin in an ovarian carcinoma cell line
36. Activation of the orphan nuclear receptor RORα induces growth arrest in androgen-independent DU 145 prostete cancer cells
37. Oncostatic activity of a thiazolidinedione derivative on human androgen-dependent prostate cancer cells
38. Transcriptional repression of RORalpha activity in human breast cancer cells by melatonin